Creating “Win-Win” R&D Collaborations with the U.S. Government
December 5 at 11:00am CST
Looking for non-dilutive funding to spur your medical product towards commercialization? Is research & development with Federal government a “black box” for your company? Attend this webinar to learn how to partner with the R&D elements of the Federal government for “win-win” collaborations that will spur medical product development. Find out which legal tools the Federal government uses to invest in breakthrough technology, which Agencies have funding for specific types of medical products, and how to protect your company’s intellectual property, technical data, and FDA regulatory position as you work with the government.
Thanks to our co-sponsors
Jeremiah Kelly’s practice centers on helping companies navigate the complexities of the U.S. Food and Drug Administration’s (FDA) regulation of drugs, biologics, medical devices, and combination products. Jeremiah helps companies from “bench to bedside.” He supports companies along the development and commercialization pathway, from pre-clinical, clinical, and pre-market applications for FDA’s approval, licensure, clearance, or authorization of medical products to post-market compliance. Prior to joining Venable, Jeremiah served as the Chief of the FDA Regulatory Law Division in the Office of the Staff Judge Advocate (JAG), U.S. Army Medical Research and Development Command (USAMRDC) and the Commissioner’s Office of the U.S. Food and Drug Administration.
